AbCellera Biologics, Inc. (ABCL)
3.49
+0.21
(+6.40%)
USD |
NASDAQ |
Mar 31, 16:00
3.55
+0.06
(+1.72%)
Pre-Market: 08:04
AbCellera Biologics Total Assets (Quarterly) : 1.357B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 42.07M |
| Oncolytics Biotech, Inc. | 5.531M |
| Aurinia Pharmaceuticals, Inc. | 770.59M |
| Edesa Biotech, Inc. | 14.71M |
| Lexaria Bioscience Corp. | 6.051M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 215.59M |
| Shareholders Equity (Quarterly) | 966.90M |
| Debt to Equity Ratio | 0.1481 |
| Current Ratio | 11.32 |
| Net Debt Paydown Yield | -1.40% |